Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kushi Kushekhar"'
Autor:
Dinh-Toi Chu, Thuy Nguyen Thi Phuong, Nguyen Le Bao Tien, Dang Khoa Tran, Vo Van Thanh, Thuy Luu Quang, Dang Tien Truong, Van Huy Pham, Vo Truong Nhu Ngoc, Thien Chu-Dinh, Kushi Kushekhar
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 3, p 708 (2020)
Bone marrow mesenchymal stem/stromal cells (BMSCs), which are known as multipotent cells, are widely used in the treatment of various diseases via their self-renewable, differentiation, and immunomodulatory properties. In-vitro and in-vivo studies ha
Externí odkaz:
https://doaj.org/article/4efc98e5d8e8482b95141a95e768c3ae
Autor:
Marcel Nijland, Rianne N. Veenstra, Lydia Visser, Chuanhui Xu, Kushi Kushekhar, Gustaaf W. van Imhoff, Philip M. Kluin, Anke van den Berg, Arjan Diepstra
Publikováno v:
OncoImmunology, Vol 6, Iss 4 (2017)
Antigen presentation by tumor cells in the context of Human Leukocyte Antigen (HLA) is generally considered to be a prerequisite for effective immune checkpoint inhibitor therapy. We evaluated cell surface HLA class I, HLA class II and cytoplasmic HL
Externí odkaz:
https://doaj.org/article/5e3fc889fd1244a6b476b3504c80cfbe
Autor:
Dinh-Toi Chu, Thuy Nguyen Thi Phuong, Nguyen Le Bao Tien, Dang-Khoa Tran, Tran-Thuy Nguyen, Vo Van Thanh, Thuy Luu Quang, Le Bui Minh, Van Huy Pham, Vo Truong Nhu Ngoc, Kushi Kushekhar, Thien Chu-Dinh
Publikováno v:
Cells, Vol 8, Iss 8, p 857 (2019)
Obesity is a global pandemic and it is well evident that obesity is associated with the development of many disorders including many cancer types. Breast cancer is one of that associated with a high mortality rate. Adipocytes, a major cellular compon
Externí odkaz:
https://doaj.org/article/88d7468003384592822bdde7dbd0b6f3
Autor:
Xin Huang, Bouke Hepkema, Ilja Nolte, Kushi Kushekhar, Theo Jongsma, Rianne Veenstra, Sibrand Poppema, Zifen Gao, Lydia Visser, Arjan Diepstra, Anke van den Berg
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31865 (2012)
HLA-A2 protects from EBV+ classical Hodgkin lymphoma (cHL) in Western Europe, but it is unknown whether this protective effect also exists in the Chinese population. We investigated the association of HLA-A2 and specific common and well documented HL
Externí odkaz:
https://doaj.org/article/fd6c9c8dd0d242fc880a781ea4fff413
Autor:
Xin Huang, Kushi Kushekhar, Ilja Nolte, Wierd Kooistra, Lydia Visser, Ilby Bouwman, Niels Kouprie, Rianne Veenstra, Gustaaf van Imhoff, Bianca Olver, Richard S Houlston, Sibrand Poppema, Arjan Diepstra, Bouke Hepkema, Anke van den Berg
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e39986 (2012)
The pathogenesis of classical Hodgkin lymphoma (cHL) involves environmental and genetic factors. To explore the role of the human leukocyte antigen (HLA) genes, we performed a case-control genotyping study in 338 Dutch cHL patients using a PCR-based
Externí odkaz:
https://doaj.org/article/d12698ac29704d118d266c64386bb8c0
Overview of genome wide association studies in classical Hodgkin lymphoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c10190e3254aa6e0110a9a494dcb3ddc
https://doi.org/10.1158/1055-9965.22438354.v1
https://doi.org/10.1158/1055-9965.22438354.v1
Overview of literature search and study selection process.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bd894d1e0cd50a634be498a809e6646
https://doi.org/10.1158/1055-9965.22438363.v1
https://doi.org/10.1158/1055-9965.22438363.v1
Both targeted and genome-wide studies have revealed genetic associations for susceptibility, prognosis, and treatment-induced secondary malignancies and toxicities in classical Hodgkin lymphoma (cHL). This review gives a systematic and comprehensive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d6102e80b4be2069735d2c0dec0857
https://doi.org/10.1158/1055-9965.c.6516319
https://doi.org/10.1158/1055-9965.c.6516319
Autor:
Jürgen Krauss, Angela Krakhardt, Stephan Eisenmann, Sebastian Ochsenreither, Kaja C.G Berg, Kushi Kushekhar, Lars-Egil Fallang, Mikkel W. Pedersen, Siri Torhaug, Karsten B. Slot, Karoline Schjetne
Publikováno v:
Cancer Research. 83:CT274-CT274
Background: VB N-01 is an open label phase 1/2a basket trial to evaluate safety, feasibility, and immunogenicity of a therapeutic DNA cancer vaccine VB10.NEO in patients with locally advanced or metastatic solid cancers. Each VB10.NEO vaccine contain
Publikováno v:
Biomarkers of the Tumor Microenvironment ISBN: 9783030989491
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::657d67eeeb3c5887b37db2d1caa55e52
https://doi.org/10.1007/978-3-030-98950-7_10
https://doi.org/10.1007/978-3-030-98950-7_10